BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22433804)

  • 21. Developing a Consistent, Reproducible Botulinum Toxin Type A Dosing Method for Upper Limb Tremor by Kinematic Analysis.
    Samotus O; Lee J; Jog M
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33917695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Botulinum toxin type A (dysport) in the complex rehabilitation of children with spastic forms of cerebral palsy].
    Zmanovskaia VA; Levitina EV; Popkov DA; Butorina MN; Pavlova OL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(7):33-6. PubMed ID: 25176264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Essential palatal tremor treated with botulinum toxin.
    Carman KB; Ozkan S; Yarar C; Yakut A
    Pediatr Neurol; 2013 May; 48(5):415-7. PubMed ID: 23583064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum Toxin in Parkinson Disease Tremor: A Randomized, Double-Blind, Placebo-Controlled Study With a Customized Injection Approach.
    Mittal SO; Machado D; Richardson D; Dubey D; Jabbari B
    Mayo Clin Proc; 2017 Sep; 92(9):1359-1367. PubMed ID: 28789780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isosorbide dinitrate ointment vs botulinum toxin A (Dysport) as the primary treatment for chronic anal fissure: a randomized multicentre study.
    Berkel AE; Rosman C; Koop R; van Duijvendijk P; van der Palen J; Klaase JM
    Colorectal Dis; 2014 Oct; 16(10):O360-6. PubMed ID: 24629060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin treatment of essential head tremor.
    Pahwa R; Busenbark K; Swanson-Hyland EF; Dubinsky RM; Hubble JP; Gray C; Koller WC
    Neurology; 1995 Apr; 45(4):822-4. PubMed ID: 7723978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of the vocal tremor scoring system.
    Bové M; Daamen N; Rosen C; Wang CC; Sulica L; Gartner-Schmidt J
    Laryngoscope; 2006 Sep; 116(9):1662-7. PubMed ID: 16955000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. More Evidence for Botulinum Toxin in Isolated or Essential Head Tremor.
    Pandey S
    Mov Disord Clin Pract; 2024 Apr; 11(4):335-336. PubMed ID: 38415504
    [No Abstract]   [Full Text] [Related]  

  • 30. Dynamic decomposition of motion in essential and parkinsonian tremor.
    Rahimi F; Debicki D; Roberts-South A; Bee C; Bapat P; Jog M
    Can J Neurol Sci; 2015 Mar; 42(2):116-24. PubMed ID: 25702954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysport (botulinum toxin type A) in routine therapeutic usage: a telephone needs assessment survey of European physicians to evaluate current awareness and adherence to product labeling changes.
    Hubble J; Schwab J; Hubert C; Abbott CC
    Clin Neuropharmacol; 2013; 36(4):122-7. PubMed ID: 23783005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections.
    Nesbitt-Hawes EM; Won H; Jarvis SK; Lyons SD; Vancaillie TG; Abbott JA
    Toxicon; 2013 Mar; 63():83-7. PubMed ID: 23220489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor.
    Van Der Walt A; Sung S; Spelman T; Marriott M; Kolbe S; Mitchell P; Evans A; Butzkueven H
    Neurology; 2012 Jul; 79(1):92-9. PubMed ID: 22753445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-World Longitudinal Experience of Botulinum Toxin Therapy for Parkinson and Essential Tremor.
    Samotus O; Mahdi Y; Jog M
    Toxins (Basel); 2022 Aug; 14(8):. PubMed ID: 36006219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Foot deformity in children with spastic forms of cerebral palsy: the treatment with botulinum toxin type A (dysport)].
    Kurenkova AL; Dutikova EM; Nikitin SS; Artemenko AR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(6):37-43. PubMed ID: 20559272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics of essential voice tremor: a study of 34 cases.
    Sulica L; Louis ED
    Laryngoscope; 2010 Mar; 120(3):516-28. PubMed ID: 20066728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.
    Kendall KA; Leonard RJ
    J Voice; 2011 Jan; 25(1):114-9. PubMed ID: 20137891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Essential tremor in the older adult: coping with primary symptoms.
    Luggen AS;
    Adv Nurse Pract; 2004 Sep; 12(9):32-6. PubMed ID: 15473446
    [No Abstract]   [Full Text] [Related]  

  • 39. [Focal dystonias and their treatment with dysport (botulinum toxin type A)].
    Orlova OR; Timerbaeva SL; Khat'kova SE; Kotliarov VV; Korenko LA; Zalialova ZA; Fal'kovskiĭ IV; Shperling LP; Antipova LN; Antipenko EA; Mingazova LR; Soĭkher MI; Krasavina DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5):81-9. PubMed ID: 22951787
    [No Abstract]   [Full Text] [Related]  

  • 40. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
    Farahvash MR; Arad S
    J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.